Amanda Gill

Amanda Gill

Partner
New York
About
Amanda Gill advises US and international entities, boards of directors, special board committees, private equity sponsors, and investment banks on mergers and acquisitions (M&A) and corporate governance matters. Her experience spans public and private company M&A transactions, tender offers, joint ventures, reverse mergers, cross-border transactions, leveraged buyouts, minority and control investments, shareholder activism, financial advisory matters, and other general corporate governance matters. Amanda represents businesses across industries, including life sciences, pharmaceuticals, technology, healthcare, financial services, consumer goods, and retail.
Areas of FocusCorporateMergers and AcquisitionsLife SciencesTechnology
Bar admissionsNew York

EXPERIENCE

  • Tubulis GmbH in its acquisition by Gilead Sciences for up to USD5 billion.
  • A Canadian multinational content-driven technology conglomerate in its acquisition of a software company and Additive AI, Inc.
  • High Liner Foods Incorporated in its acquisition of Mrs. Paul’s and Van de Kamp’s Brands from Conagra Brands, Inc.
  • Teleflex in its acquisition of the vascular intervention business from Biotronik SE & Co. KG for a cash payment of EUR760 million.
  • SpringWorks Therapeutics, Inc. with its USD3.9 billion sale to Merck KGaA
  • Lumine Group, Inc. in its acquisition of Synchronoss Technologies, Inc.
  • Cycle Group Holdings Limited with its acquisition of Applied Therapeutics, Inc.
  • Kronos Bio, Inc. with its strategic review process and take-private by Concentra Biosciences, LLC.
  • Ikena Oncology Inc. in its business combination with Inmagene Biopharmaceuticals.
  • Illumina in its acquisition of Fluent Biosciences Inc.
  • Fusion Pharmaceuticals Inc. in its USD2.4 billion (upfront cash and CVR) sale to AstraZeneca.
  • Harpoon Therapeutics Inc. in its USD700 million sale to Merck.
  • 2seventy bio in the divestiture of its oncology and autoimmune pipeline to Regeneron.
  • Amedisys in its combination with Optum.
  • CDK Global in its sale to Brookfield Business Partners.
  • Global Infrastructure Partners in its acquisition of a leading global data center developer and operator.
  • An information technology service management company in its sale to a leading global alternative asset manager.
  • LSC Communications, Inc. in its merger with Quad/Graphics, Inc.
  • Terumo Corporation (Japan) in its acquisition of certain vascular closure product lines and access technologies from Abbott Laboratories and a global medical device company.
  • IBM in its acquisition of Apptio, Inc. from Vista Equity Partners
  • Aptiv PLC in its acquisition of Wind River from TPG Capital
  • A multinational food company in its sale of its natural, grated, cultured and specialty cheese businesses to Groupe Lactalis. 
  • United Rentals, Inc. in its acquisition of NES Rentals Holdings II, Inc., BakerCorp International Holdings, Inc., BlueLine Rental, and Neff Corporation.
Education
  • J.D., University of Virginia School of Law
  • B.A., Duke University
    summa cum laude
    Phi Beta Kappa

AWARDS

The Legal 500 United States

  • Recommended, Life Sciences (2025)

Prior Experience

Prior to joining DLA Piper, Amanda was a partner in the M&A / Corporate Governance and Life Sciences practice at an international law firm.

Additional Information

During law school, Amanda served as the editor-in-chief of the Virginia Journal of Law and Technology.

Memberships

Member, American Bar Association

My latest insights

News
White_architecture_detail_on_blue_sky_PPT

DLA Piper advises Motorola Solutions on US$1.5 billion acquisition of D-Fend Solutions

1 June 2026 .1 minute read

News

DLA Piper bolsters public and private company M&A capabilities with Partner Amanda Gill

15 May 2026

Connect

Phone

+1 212 335 4775
(Work, New York)
CallvCardLinkedInPrint